Literature DB >> 1167631

Estrogen-withdrawal migraine. II. Attempted prophylaxis by continuous estradiol administration.

B W Somerville.   

Abstract

Prophylaxis of menstrual migraine was attempted in five women, using estradiol implants. The treatment was successful in suppressing ovulation and in producing high, although fluctuating, levels of estradiol in the plasma. Clinically this was associated with severe menstrual disturbance. The regular periodicity of the headaches was lost, but clinical benefit was unpredictable, with some patients actually experiencing more headaches than before the treatment. The administration of progesterone against a background of prolonged exposure to high estrogen levels did not provoke migraine, nor in any case did its subsequent withdrawal result in migraine. These findings cast further doubt on the importance of progesterone withdrawal in the etiology of menstrual migraine.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1167631     DOI: 10.1212/wnl.25.3.245

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

1.  Menstrual migraine: therapeutic approaches.

Authors:  E Anne Macgregor
Journal:  Ther Adv Neurol Disord       Date:  2009-09       Impact factor: 6.570

2.  Behavioral effects and mechanisms of migraine pathogenesis following estradiol exposure in a multibehavioral model of migraine in rat.

Authors:  Lydia M M Vermeer; Eugene Gregory; Michelle K Winter; Kenneth E McCarson; Nancy E J Berman
Journal:  Exp Neurol       Date:  2014-09-28       Impact factor: 5.330

3.  Symptomatic headaches.

Authors:  G Bono; P Merlo; G Sances; F Tancioni; M Mauri
Journal:  Ital J Neurol Sci       Date:  1995-12

Review 4.  Prevention and treatment of menstrual migraine.

Authors:  E Anne MacGregor
Journal:  Drugs       Date:  2010-10-01       Impact factor: 9.546

5.  [Medical therapy for menstrual migraine].

Authors:  V Pfaffenrath; A Goes
Journal:  Schmerz       Date:  1996-06-17       Impact factor: 1.107

Review 6.  Genetics of menstrual migraine: the epidemiological evidence.

Authors:  Michael Bjørn Russell
Journal:  Curr Pain Headache Rep       Date:  2010-10

Review 7.  Current and prospective pharmacological targets in relation to antimigraine action.

Authors:  Suneet Mehrotra; Saurabh Gupta; Kayi Y Chan; Carlos M Villalón; David Centurión; Pramod R Saxena; Antoinette MaassenVanDenBrink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-15       Impact factor: 3.000

8.  Exposure to bisphenol A exacerbates migraine-like behaviors in a multibehavior model of rat migraine.

Authors:  Lydia M M Vermeer; Eugene Gregory; Michelle K Winter; Kenneth E McCarson; Nancy E J Berman
Journal:  Toxicol Sci       Date:  2013-11-04       Impact factor: 4.849

Review 9.  Migraine headache in perimenopausal and menopausal women.

Authors:  E Anne MacGregor
Journal:  Curr Pain Headache Rep       Date:  2009-10

Review 10.  [Migraine and hormones: what can we be certain of?].

Authors:  U Bingel
Journal:  Schmerz       Date:  2008-02       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.